Point72 Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-542,164
Closed -$52.8M 1228
2020
Q3
$52.8M Buy
542,164
+27,358
+5% +$3.15M 0.27% 89
2020
Q2
$63.2M Buy
514,806
+439,523
+584% +$49.9M 0.41% 57
2020
Q1
$6.59M Sell
75,283
-538,885
-88% -$57.1M 0.05% 353
2019
Q4
$64.2M Sell
614,168
-296,867
-33% -$33.3M 0.34% 77
2019
Q3
$105M Buy
911,035
+240,524
+36% +$36.5M 0.64% 28
2019
Q2
$116M Buy
670,511
+635,895
+1,837% +$110M 0.6% 32
2019
Q1
$5.83M Sell
34,616
-281,600
-89% -$41.9M 0.03% 528
2018
Q4
$30.8M Buy
316,216
+232,016
+276% +$30.4M 0.15% 177
2018
Q3
$14.5M Sell
84,200
-56,900
-40% -$8.21M 0.06% 377
2018
Q2
$19.7M Sell
141,100
-222,200
-61% -$31.6M 0.08% 308
2018
Q1
$40.9M Sell
363,300
-38,365
-10% -$4.82M 0.17% 163
2017
Q4
$53M Buy
401,665
+243,322
+154% +$28.6M 0.23% 122
2017
Q3
$16.1M Buy
158,343
+25,543
+19% +$2.74M 0.07% 305
2017
Q2
$13.3M Buy
132,800
+90,200
+212% +$9.71M 0.07% 334
2017
Q1
$5.15M Buy
42,600
+13,000
+44% +$1.59M 0.03% 519
2016
Q4
$3.31M Sell
29,600
-123,063
-81% -$14.8M 0.02% 494
2016
Q3
$20.3M Buy
+152,663
New +$14.6M 0.14% 180
2016
Q2
Sell
-508,143
Closed -$36.7M 924
2016
Q1
$36.7M Buy
508,143
+480,243
+1,721% +$26.3M 0.28% 94
2015
Q4
$1.94M Buy
+27,900
New +$2.27M 0.02% 552

Other funds holding GWPH

Point72 Asset Management's GWPH Position: Q4 2020 in Review

Point72 Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 542,164 shares — an estimated $52.8M sold.

Point72 Asset Management first reported a position in GWPH in Q4 2015 and held it in 19 quarters. The position peaked at $116M in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Point72 Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Point72 Asset Management sold 542,164 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $52.8M.
  • Point72 Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 19 quarters.
  • Point72 Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $116M in Q2 2019.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Point72 Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.